• 8317 Citations
  • 27 Scopus h-Index
20022019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2002 2019

Filter
Article
2019

Drug-associated vasculitis occurring after treatment with pembrolizumab

Tolaymat, O. A., Pinkston, O., Wang, B., Schenk, W. B., Joseph, R. W., Mergo, P. J. & Berianu, F., Aug 1 2019, In : Rheumatology (Oxford, England). 58, 8, p. 1501-1503 3 p.

Research output: Contribution to journalArticle

Vasculitis
Pharmaceutical Preparations
pembrolizumab
22 Citations (Scopus)

Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001

Hamid, O., Robert, C., Daud, A., Hodi, F. S., Hwu, W. J., Kefford, R., Wolchok, J. D., Hersey, P., Joseph, R. W., Weber, J. S., Dronca, R. S., Mitchell, T. C., Patnaik, A., Zarour, H. M., Joshua, A. M., Zhao, Q., Jensen, E., Ahsan, S., Ibrahim, N. & Ribas, A., Apr 1 2019, In : Annals of oncology : official journal of the European Society for Medical Oncology. 30, 4, p. 582-588 7 p.

Research output: Contribution to journalArticle

Open Access
Melanoma
Survival
Disease-Free Survival
pembrolizumab
Therapeutics
1 Citation (Scopus)

Inositol hexaphosphate plus inositol induced complete remission in stage IV melanoma: a case report

Khurana, S., Baldeo, C. & Joseph, R. W., Jun 1 2019, In : Melanoma research. 29, 3, p. 322-324 3 p.

Research output: Contribution to journalArticle

Phytic Acid
Inositol
Melanoma
Vitamin B Complex
Nuts
2 Citations (Scopus)

Patient and Oncology Nurse Preferences for the Treatment Options in Advanced Melanoma: A Discrete Choice Experiment

Liu, F. X., Witt, E. A., Ebbinghaus, S., Dibonaventura Beyer, G., Basurto, E. & Joseph, R. W., Jan 1 2019, In : Cancer Nursing. 42, 1, p. E52-E59

Research output: Contribution to journalArticle

Melanoma
Nurses
Disease-Free Survival
Appointments and Schedules
Therapeutics
2018
3 Citations (Scopus)

Association between programmed death-Ligand 1 expression and the vascular endothelial growth factor pathway in angiosarcoma

Bagaria, S. P., Gatalica, Z., Maney, T., Serie, D., Parasramka, M., Attia, S., Krishna, M. & Joseph, R. W., Mar 22 2018, In : Frontiers in Oncology. 8, MAR, 71.

Research output: Contribution to journalArticle

Hemangiosarcoma
Vascular Endothelial Growth Factor A
Ligands
Neoplasms
Gene Expression
35 Citations (Scopus)

Baseline tumor size is an independent prognostic factor for overall survival in patients with melanoma treated with pembrolizumab

Joseph, R. W., Elassaiss-Schaap, J., Kefford, R., Hwu, W. J., Wolchok, J. D., Joshua, A. M., Ribas, A., Hodi, F. S., Hamid, O., Robert, C., Daud, A., Dronca, R. S., Hersey, P., Weber, J. S., Patnaik, A., De Alwis, D. P., Perrone, A., Zhang, J., Kang, S. P., Ebbinghaus, S. & 2 others, Anderson, K. M. & Gangadhar, T. C., Oct 15 2018, In : Clinical Cancer Research. 24, 20, p. 4960-4967 8 p.

Research output: Contribution to journalArticle

Melanoma
Survival
Neoplasms
pembrolizumab
Ligands
109 Citations (Scopus)

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

McDermott, D. F., Huseni, M. A., Atkins, M. B., Motzer, R. J., Rini, B. I., Escudier, B., Fong, L., Joseph, R. W., Pal, S. K., Reeves, J. A., Sznol, M., Hainsworth, J., Rathmell, W. K., Stadler, W. M., Hutson, T., Gore, M. E., Ravaud, A., Bracarda, S., Suárez, C., Danielli, R. & 12 others, Gruenwald, V., Choueiri, T. K., Nickles, D., Jhunjhunwala, S., Piault-Louis, E., Thobhani, A., Qiu, J., Chen, D. S., Hegde, P. S., Schiff, C., Fine, G. D. & Powles, T., Jun 1 2018, In : Nature Medicine. 24, 6, p. 749-757 9 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Vascular Endothelial Growth Factor A
Disease-Free Survival
Cells
Confidence Intervals
80 Citations (Scopus)

Durable complete response after discontinuation of pembrolizumab in patients with metastatic melanoma

Robert, C., Ribas, A., Hamid, O., Daud, A., Wolchok, J. D., Joshua, A. M., Hwu, W. J., Weber, J. S., Gangadhar, T. C., Joseph, R. W., Dronca, R. S., Patnaik, A., Zarour, H., Kefford, R., Hersey, P., Zhang, J., Anderson, J., Diede, S. J., Ebbinghaus, S. & Hodi, F. S., Jun 10 2018, In : Journal of Clinical Oncology. 36, 17, p. 1668-1674 7 p.

Research output: Contribution to journalArticle

Melanoma
pembrolizumab
Observation
Therapeutics
Disease-Free Survival

Erratum to: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma (Nature Medicine, (2018), 24, 6, (749-757), 10.1038/s41591-018-0053-3)

McDermott, D. F., Huseni, M. A., Atkins, M. B., Motzer, R. J., Rini, B. I., Escudier, B., Fong, L., Joseph, R. W., Pal, S. K., Reeves, J. A., Sznol, M., Hainsworth, J., Rathmell, W. K., Stadler, W. M., Hutson, T., Gore, M. E., Ravaud, A., Bracarda, S., Suárez, C., Danielli, R. & 12 others, Gruenwald, V., Choueiri, T. K., Nickles, D., Jhunjhunwala, S., Piault-Louis, E., Thobhani, A., Qiu, J., Chen, D. S., Hegde, P. S., Schiff, C., Fine, G. D. & Powles, T., Jan 1 2018, (Accepted/In press) In : Nature Medicine.

Research output: Contribution to journalArticle

Solar System
Renal Cell Carcinoma
Medicine
Cells
HTML

Factors associated with immunotherapy selection in patients with advanced melanoma

Joseph, R. W., Shillington, A. C., Macahilig, C., Diede, S. J., Dave, V., Harshaw, Q. & Liu, F. X., Nov 1 2018, In : Immunotherapy. 10, 16, p. 1361-1369 9 p.

Research output: Contribution to journalArticle

Immunotherapy
Patient Selection
Melanoma
Odds Ratio
Logistic Models
60 Citations (Scopus)

High response rate to PD-1 blockade in desmoplastic melanomas

Eroglu, Z., Zaretsky, J. M., Hu-Lieskovan, S., Kim, D. W., Algazi, A., Johnson, D. B., Liniker, E., Kong, B., Munhoz, R., Rapisuwon, S., Gherardini, P. F., Chmielowski, B., Wang, X., Shintaku, I. P., Wei, C., Sosman, J. A., Joseph, R. W., Postow, M. A., Carlino, M. S., Hwu, W. J. & 5 others, Scolyer, R. A., Messina, J., Cochran, A. J., Long, G. V. & Ribas, A., Jan 18 2018, In : Nature. 553, 7688, p. 347-350 4 p.

Research output: Contribution to journalArticle

Melanoma
Cell Death
CD274 Antigen
Neoplasms
Exome
14 Citations (Scopus)

Quantitative spatial profiling of PD-1/PD-L1 interaction and HLA-DR/IDO-1 predicts improved outcomes of anti-PD-1 therapies in metastatic melanoma

Johnson, D. B., Bordeaux, J., Kim, J. Y., Vaupel, C., Rimm, D. L., Ho, T. H., Joseph, R. W., Daud, A. I., Conry, R. M., Gaughan, E. M., Hernandez-Aya, L. F., Dimou, A., Funchain, P., Smithy, J., Witte, J. S., McKee, S. B., Ko, J., Wrangle, J. M., Dabbas, B., Tangri, S. & 5 others, Lameh, J., Hall, J., Markowitz, J., Balko, J. M. & Dakappagari, N., Nov 1 2018, In : Clinical Cancer Research. 24, 21, p. 5250-5260 11 p.

Research output: Contribution to journalArticle

HLA-DR Antigens
Melanoma
Biomarkers
Survival
Therapeutics
8 Citations (Scopus)

Sentinel lymph node biopsy in Merkel cell carcinoma: The Mayo Clinic experience of 150 patients

Sims, J. R., Grotz, T. E., Pockaj, B. A., Joseph, R. W., Foote, R. L., Otley, C. C., Weaver, A. L., Jakub, J. W. & Price, D. L., Mar 1 2018, In : Surgical Oncology. 27, 1, p. 11-17 7 p.

Research output: Contribution to journalArticle

Merkel Cell Carcinoma
Sentinel Lymph Node Biopsy
Recurrence
Sentinel Lymph Node
Neoplasm Metastasis
2017
523 Citations (Scopus)

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

Balar, A. V., Galsky, M. D., Rosenberg, J. E., Powles, T., Petrylak, D. P., Bellmunt, J., Loriot, Y., Necchi, A., Hoffman-Censits, J., Perez-Gracia, J. L., Dawson, N. A., van der Heijden, M. S., Dreicer, R., Srinivas, S., Retz, M. M., Joseph, R. W., Drakaki, A., Vaishampayan, U. N., Sridhar, S. S., Quinn, D. I. & 15 others, Durán, I., Shaffer, D. R., Eigl, B. J., Grivas, P. D., Yu, E. Y., Li, S., Kadel, E. E., Boyd, Z., Bourgon, R., Hegde, P. S., Mariathasan, S., Thåström, A. C., Abidoye, O. O., Fine, G. D. & Bajorin, D. F., Jan 7 2017, In : The Lancet. 389, 10064, p. 67-76 10 p.

Research output: Contribution to journalArticle

Cisplatin
Carcinoma
Therapeutics
Ligands
MPDL3280A
25 Citations (Scopus)

Atezolizumab in platinum-treated locally advanced or metastatic urothelial carcinoma: Post-progression outcomes from the phase II IMvigor210 study

Necchi, A., Joseph, R. W., Loriot, Y., Hoffman-Censits, J., Perez-Gracia, J. L., Petrylak, D. P., Derleth, C. L., Tayama, D., Zhu, Q., Ding, B., Kaiser, C. & Rosenberg, J. E., Dec 1 2017, In : Annals of Oncology. 28, 12, p. 3044-3050 7 p.

Research output: Contribution to journalArticle

Platinum
Carcinoma
Safety
MPDL3280A
Therapeutics
9 Citations (Scopus)

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor

Eckel-Passow, J. E., Serie, D. J., Cheville, J. C., Ho, T. H., Kapur, P., Brugarolas, J., Thompson, R. H., Leibovich, B. C., Kwon, E. D., Joseph, R. W. & Parker, A., Mar 21 2017, In : BMC Urology. 17, 1, p. 1-7 7 p.

Research output: Contribution to journalArticle

Neoplasms
Renal Cell Carcinoma
Clear-cell metastatic renal cell carcinoma
Mutation
Immunohistochemistry
7 Citations (Scopus)

Clinical features of acquired resistance to anti-PD-1 therapy in advanced melanoma

Wang, D. Y., Eroglu, Z., Ozgun, A., Leger, P. D., Zhao, S., Ye, F., Luke, J. J., Joseph, R. W., Haq, R., Ott, P. A., Hodi, F. S., Sosman, J. A., Johnson, D. B. & Buchbinder, E. I., May 1 2017, In : Cancer immunology research. 5, 5, p. 357-362 6 p.

Research output: Contribution to journalArticle

Melanoma
Survival
Therapeutics
Radiation
Disease-Free Survival
1 Citation (Scopus)

Comprehensive genomic profiling of a rare thyroid follicular dendritic cell sarcoma

Davila, J. I., Starr, J. S., Attia, S., Wang, C., Knudson, R. A., Necela, B. M., Sarangi, V., Sun, Z. D., Ren, Y., Casler, J. D., Menke, D. M., Oliver, G. R., Joseph, R. W., Copland, J. A. III., Parker, A., Kocher, J-P., Thompson, E. A., Smallridge, R. C. & Asmann, Y., Sep 15 2017, In : Rare Tumors. 9, 2, p. 50-53 4 p., 6834.

Research output: Contribution to journalArticle

Follicular Dendritic Cell Sarcoma
Missense Mutation
Mutation
Gene Fusion
Neoplasms
16 Citations (Scopus)

Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes

Ho, T. H., Serie, D. J., Parasramka, M., Cheville, J. C., Bot, B. M., Tan, W., Wang, L. M., Joseph, R. W., Hilton, T., Leibovich, B. C., Parker, A. & Eckel-Passow, J. E., 2017, In : Annals of Oncology. 28, 3, p. 604-610 7 p.

Research output: Contribution to journalArticle

Gene Expression Profiling
Renal Cell Carcinoma
Extracellular Matrix
Up-Regulation
Neoplasm Metastasis
6 Citations (Scopus)

Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States: An Expanded Access Program

Gangadhar, T. C., Hwu, W. J., Postow, M. A., Hamid, O., Daud, A., Dronca, R. S., Joseph, R. W., O'Day, S. J., Hodi, F. S., Pavlick, A. C., Kluger, H., Oxborough, R. P., Yang, A., Gazdoiu, M., Kush, D. A., Ebbinghaus, S. & Salama, A. K. S., 2017, In : Journal of Immunotherapy. 40, 9, p. 334-340 7 p.

Research output: Contribution to journalArticle

Safety
Melanoma
Confidence Intervals
Therapeutics
pembrolizumab
40 Citations (Scopus)

Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanoma

Zimmer, L., Apuri, S., Eroglu, Z., Kottschade, L. A., Forschner, A., Gutzmer, R., Schlaak, M., Heinzerling, L., Krackhardt, A. M., Loquai, C., Markovic, S. N., Joseph, R. W., Markey, K., Utikal, J. S., Weishaupt, C., Goldinger, S. M., Sondak, V. K., Zager, J. S., Schadendorf, D. & Khushalani, N. I., Apr 1 2017, In : European Journal of Cancer. 75, p. 47-55 9 p.

Research output: Contribution to journalArticle

Melanoma
Cell Death
Treatment Failure
Therapeutics
ipilimumab
12 Citations (Scopus)

Multicenter Validation of Enhancer of Zeste Homolog 2 Expression as an Independent Prognostic Marker in Localized Clear Cell Renal Cell Carcinoma

Ho, T. H., Eckel-Passow, J. E., Cheville, J., Christie, A., Joseph, R. W., Serie, D. J., Cheville, J. C., Thompson, R. H., Homayoun, F., Joseph, R. W., Brugarolas, J. & Parker, A., Nov 10 2017, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 35, 32, p. 3706-3713 8 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Necrosis
Atlases
Neoplasms
Enhancer of Zeste Homolog 2 Protein
4 Citations (Scopus)

NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab±everolimus for metastatic melanoma

Mc Williams, R. R., Allred, J. B., Slostad, J. A., Katipamula, R., Dronca, R. S., Rumilla, K. M., Erickson, L. A., Bryce, A. H., Joseph, R. W., Kottschade, L. A., King, D. M., Leitch, J. M. & Markovic, S. N., 2017, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Carboplatin
Paclitaxel
Melanoma
Disease-Free Survival
Therapeutics
4 Citations (Scopus)

Non–clear cell renal cell carcinomas: Biological insights and therapeutic challenges and opportunities

Malouf, G. G., Joseph, R. W., Shah, A. Y. & Tannir, N. M., May 1 2017, In : Clinical Advances in Hematology and Oncology. 15, 5, p. 409-418 10 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Orphaned Children
Kidney Neoplasms
Therapeutics
Platinum
6 Citations (Scopus)

Patient and oncologist preferences for attributes of treatments in advanced melanoma: A discrete choice experiment

Liu, F. X., Witt, E. A., Ebbinghaus, S., Beyer, G. D., Shinde, R., Basurto, E. & Joseph, R. W., Aug 14 2017, In : Patient Preference and Adherence. 11, p. 1389-1399 11 p.

Research output: Contribution to journalArticle

Patient Preference
Melanoma
event
experiment
Survival
11 Citations (Scopus)

The feasibility and safety of surgery in patients receiving immune checkpoint inhibitors: A retrospective study

Elias, A. W., Kasi, P. M., Stauffer, J. A., Thiel, D. D., Colibaseanu, D. T., Mody, K., Joseph, R. W. & Bagaria, S. P., Jun 12 2017, In : Frontiers in Oncology. 7, JUN, 121.

Research output: Contribution to journalArticle

Retrospective Studies
Safety
Neurosurgery
Abdominal Wall
Ventricular Fibrillation
2016
397 Citations (Scopus)

Association of pembrolizumab with tumor response and survival among patients with advanced melanoma

Ribas, A., Hamid, O., Daud, A., Hodi, F. S., Wolchok, J. D., Kefford, R., Joshua, A. M., Patnaik, A., Hwu, W. J., Weber, J. S., Gangadhar, T. C., Hersey, P., Dronca, R. S., Joseph, R. W., Zarour, H., Chmielowski, B., Lawrence, D. P., Algazi, A., Rizvi, N. A., Hoffner, B. & 8 others, Mateus, C., Gergich, K., Lindia, J. A., Giannotti, M., Li, X. N., Ebbinghaus, S., Kang, S. P. & Robert, C., Apr 19 2016, In : JAMA - Journal of the American Medical Association. 315, 15, p. 1600-1609 10 p.

Research output: Contribution to journalArticle

Melanoma
Survival
Neoplasms
Survival Rate
Disease-Free Survival
2 Citations (Scopus)

A Study of Combination Bicalutamide and Raloxifene for Patients With Castration-Resistant Prostate Cancer

Ho, T. H., Nunez-Nateras, R., Hou, Y. X., Bryce, A. H., Northfelt, D. W., Dueck, A., Wong, B., Stanton, M. L., Joseph, R. W. & Castle, E. P., Jul 8 2016, (Accepted/In press) In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
Estrogen Receptors
Quality of Life
Therapeutics
1360 Citations (Scopus)

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: A single-arm, multicentre, phase 2 trial

Rosenberg, J. E., Hoffman-Censits, J., Powles, T., van der Heijden, M. S., Balar, A. V., Necchi, A., Dawson, N., O'Donnell, P. H., Balmanoukian, A., Loriot, Y., Srinivas, S., Retz, M. M., Grivas, P., Joseph, R. W., Galsky, M. D., Fleming, M. T., Petrylak, D. P., Perez-Gracia, J. L., Burris, H. A., Castellano, D. & 11 others, Canil, C., Bellmunt, J., Bajorin, D., Nickles, D., Bourgon, R., Frampton, G. M., Cui, N., Mariathasan, S., Abidoye, O., Fine, G. D. & Dreicer, R., 2016, (Accepted/In press) In : The Lancet.

Research output: Contribution to journalArticle

Platinum
Carcinoma
Drug Therapy
Ligands
Therapeutics
56 Citations (Scopus)

Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression

Joseph, R. W., Kapur, P., Serie, D. J., Parasramka, M., Ho, T. H., Cheville, J. C., Frenkel, E., Parker, A. & Brugarolas, J., Jan 1 2016, In : Journal of Urology. 195, 1, p. 180-187 8 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Neoplasms
Proportional Hazards Models
Necrosis
Immunohistochemistry
14 Citations (Scopus)

Clear Cell Type A and B Molecular Subtypes in Metastatic Clear Cell Renal Cell Carcinoma: Tumor Heterogeneity and Aggressiveness

Serie, D. J., Joseph, R. W., Cheville, J. C., Ho, T. H., Parasramka, M., Hilton, T., Thompson, R. H., Leibovich, B. C., Parker, A. & Eckel-Passow, J. E., 2016, (Accepted/In press) In : European Urology.

Research output: Contribution to journalArticle

Neoplasms
Renal Cell Carcinoma
Clear-cell metastatic renal cell carcinoma
Kidney Neoplasms
Confidence Intervals
16 Citations (Scopus)

Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response

Ho, T. H., Choueiri, T. K., Wang, K., Karam, J. A., Chalmers, Z., Frampton, G., Elvin, J. A., Johnson, A., Liu, X., Lin, Y., Joseph, R. W., Stanton, M. L., Miller, V. A., Stephens, P. J., Ross, J. S., Ali, S. M. & Pal, S. K., Jun 1 2016, In : European Urology Focus. 2, 2, p. 204-209 6 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Vascular Endothelial Growth Factor A
Sirolimus
Vascular Endothelial Growth Factor Receptor
Therapeutics
7 Citations (Scopus)

Detection of tumor-associated cells in cryopreserved peripheral blood mononuclear cell samples for retrospective analysis

Zhu, P., Stanton, M. L., Castle, E. P., Joseph, R. W., Adams, D. L., Li, S., Amstutz, P., Tang, C. M. & Ho, T. H., Jul 2 2016, In : Journal of Translational Medicine. 14, 1, 198.

Research output: Contribution to journalArticle

Microfiltration
Macrophages
Cryopreservation
Tumors
Blood Cells
301 Citations (Scopus)

Evaluation of immune-related response criteria and RECIST v1.1 in patients with advanced melanoma treated with Pembrolizumab

Hodi, F. S., Hwu, W. J., Kefford, R., Weber, J. S., Daud, A., Hamid, O., Patnaik, A., Ribas, A., Robert, C., Gangadhar, T. C., Joshua, A. M., Hersey, P., Dronca, R. S., Joseph, R. W., Hille, D., Xue, D., Li, X. N., Kang, S. P., Ebbinghaus, S., Perrone, A. & 1 others, Wolchok, J. D., May 1 2016, In : Journal of Clinical Oncology. 34, 13, p. 1510-1517 8 p.

Research output: Contribution to journalArticle

Melanoma
Immune System Diseases
Response Evaluation Criteria in Solid Tumors
pembrolizumab
Withholding Treatment
18 Citations (Scopus)

Loss of histone H3 lysine 36 trimethylation is associated with an increased risk of renal cell carcinoma-specific death

Ho, T. H., Kapur, P., Joseph, R. W., Serie, D. J., Eckel-Passow, J. E., Tong, P., Wang, J., Castle, E. P., Stanton, M. L., Cheville, J. C., Jonasch, E., Brugarolas, J. & Parker, A., Jan 1 2016, In : Modern Pathology. 29, 1, p. 34-42 9 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Histones
Lysine
Survival
Atlases
113 Citations (Scopus)

Melanoma, version 2.2016 clinical practice guidelines in oncology

Coit, D. G., Thompson, J. A., Algazi, A., Andtbacka, R., Bichakjian, C. K., Carson, W. E., Daniels, G. A., DiMaio, D., Ernstoff, M., Fields, R. C., Fleming, M. D., Gonzalez, R., Guild, V., Halpern, A. C., Hodi, F. S., Joseph, R. W., Lange, J. R., Martini, M. C., Materin, M. A., Olszanski, A. J. & 11 others, Ross, M. I., Salama, A. K., Skitzki, J., Sosman, J., Swetter, S. M., Tanabe, K. K., Torres-Roca, J. F., Trisal, V., Urist, M. M., McMillian, N. & Engh, A., Apr 1 2016, In : JNCCN Journal of the National Comprehensive Cancer Network. 14, 4, p. 450-473 24 p.

Research output: Contribution to journalArticle

Practice Guidelines
Melanoma
Therapeutics
Intralesional Injections
Immunotherapy
42 Citations (Scopus)

NCCN Guidelines® insights: Melanoma, version 3.2016: Featured updates to the NCCN Guidelines

Coit, D. G., Thompson, J. A., Algazi, A., Andtbacka, R., Bichakjian, C. K., Iii, W. E. C., Daniels, G. A., Dimaio, D., Fields, R. C., Fleming, M. D., Gastman, B., Gonzalez, R., Guild, V., Johnson, D., Joseph, R. W., Lange, J. R., Martini, M. C., Materin, M. A., Olszanski, A. J., Ott, P. & 11 others, Gupta, A. P., Ross, M. I., Salama, A. K., Skitzki, J., Swetter, S. M., Tanabe, K. K., Torres-Roca, J. F., Trisal, V., Urist, M. M., McMillian, N. & Engh, A., Aug 1 2016, In : JNCCN Journal of the National Comprehensive Cancer Network. 14, 8, p. 945-958 14 p.

Research output: Contribution to journalArticle

Melanoma
Guidelines
Therapeutics
189 Citations (Scopus)

Programmed death-ligand 1 expression and response to the anti-programmed death 1 antibody pembrolizumab in melanoma

Daud, A. I., Wolchok, J. D., Robert, C., Hwu, W. J., Weber, J. S., Ribas, A., Hodi, F. S., Joshua, A. M., Kefford, R., Hersey, P., Joseph, R. W., Gangadhar, T. C., Dronca, R. S., Patnaik, A., Zarour, H., Roach, C., Toland, G., Lunceford, J. K., Li, X. N., Emancipator, K. & 4 others, Dolled-Filhart, M., Kang, S. P., Ebbinghaus, S. & Hamid, O., Dec 1 2016, In : Journal of Clinical Oncology. 34, 34, p. 4102-4109 8 p.

Research output: Contribution to journalArticle

Melanoma
Ligands
Antibodies
Disease-Free Survival
Neoplasms
20 Citations (Scopus)

Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma

Rini, B. I., McDermott, D. F., Hammers, H., Bro, W., Bukowski, R. M., Faba, B., Faba, J., Figlin, R. A., Hutson, T., Jonasch, E., Joseph, R. W., Leibovich, B. C., Olencki, T., Pantuck, A. J., Quinn, D. I., Seery, V., Voss, M. H., Wood, C. G., Wood, L. S. & Atkins, M. B., Nov 15 2016, In : Journal for ImmunoTherapy of Cancer. 4, 1, 81.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Immunotherapy
Neoplasms
Vascular Endothelial Growth Factors
Therapeutics
9 Citations (Scopus)

Treatment of in-transit and metastatic melanoma in two patients treated with ipilimumab and topical imiquimod

Joseph, R. W., Cappel, M., Tzou, K., Bagaria, S., Gilstrap, C., Swaika, A. & Jambusaria-Pahlajani, A., Aug 1 2016, In : Melanoma Research. 26, 4, p. 409-412 4 p.

Research output: Contribution to journalArticle

imiquimod
Melanoma
Toll-Like Receptor 7
Skin
Therapeutics
2 Citations (Scopus)

Validation of Gene Expression Signatures to Identify Low-risk Clear-cell Renal Cell Carcinoma Patients at Higher Risk for Disease-related Death

Parasramka, M., Serie, D. J., Asmann, Y., Eckel-Passow, J. E., Castle, E. P., Stanton, M. L., Leibovich, B. C., Thompson, R. H., Thompson, E. A., Parker, A., Ho, T. H. & Joseph, R. W., Dec 15 2016, In : European Urology Focus. 2, 6, p. 608-615 8 p.

Research output: Contribution to journalArticle

Transcriptome
Renal Cell Carcinoma
Genes
Paraffin
Formaldehyde
2015
6 Citations (Scopus)

A multidisciplinary biospecimen bank of renal cell carcinomas compatible with discovery platforms at Mayo Clinic, Scottsdale, Arizona

Ho, T. H., Nateras, R. N., Yan, H. D., Park, J. G., Jensen, S., Borges, C., Lee, J. H., Champion, M. D., Tibes, R., Bryce, A. H., Carballido, E. M., Todd, M. A., Joseph, R. W., Wong, W. W., Parker, A., Stanton, M. L. & Castle, E. P., Jul 16 2015, In : PLoS One. 10, 7, e0132831.

Research output: Contribution to journalArticle

kidney cells
Renal Cell Carcinoma
carcinoma
Cells
RNA

Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis

Eckel-Passow, J. E., Igel, D. A., Serie, D. J., Joseph, R. W., Ho, T. H., Cheville, J. C. & Parker, A. S., Feb 1 2015, In : Urologic Oncology. 33, 2

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Atlases
Genome
RNA
Necrosis
4 Citations (Scopus)

Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis

Eckel-Passow, J. E., Igel, D. A., Serie, D. J., Joseph, R. W., Ho, T. H., Cheville, J. C. & Parker, A., Feb 1 2015, In : Urologic Oncology. 33, 2

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Atlases
Genome
RNA
Necrosis
2 Citations (Scopus)
Renal Cell Carcinoma
Atlases
Genome
RNA
Necrosis
119 Citations (Scopus)

Current state of anti-PD-L1 and anti-PD-1 agents in cancer therapy

Swaika, A., Hammond, W. A. & Joseph, R. W., Oct 1 2015, In : Molecular Immunology. 67, 2, p. 4-17 14 p.

Research output: Contribution to journalArticle

Ligands
Neoplasms
Immunotherapy
Immune System
Therapeutics
9 Citations (Scopus)

Follicular dendritic cell sarcoma presenting as a thyroid mass

Starr, J. S., Attia, S., Joseph, R. W., Menke, D., Casler, J. & Smallridge, R. C., Jun 10 2015, In : Journal of Clinical Oncology. 33, 17, p. e74-e76

Research output: Contribution to journalArticle

Follicular Dendritic Cell Sarcoma
Thyroid Gland
27 Citations (Scopus)

High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma

Ho, T. H., Park, I. Y., Zhao, H., Tong, P., Champion, M. D., Yan, H. D., Monzon, F. A., Hoang, A., Tamboli, P., Parker, A., Joseph, R. W., Qiao, W., Dykema, K., Tannir, N. M., Castle, E. P., Nunez-Nateras, R., Teh, B. T., Wang, J., Walker, C. L., Hung, M. C. & 1 others, Jonasch, E., Jun 15 2015, (Accepted/In press) In : Oncogene.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Histones
Lysine
Neoplasm Metastasis
Kidney
56 Citations (Scopus)

Lichenoid dermatitis in three patients with metastatic melanoma treated with anti-PD-1 therapy

Joseph, R. W., Cappel, M., Goedjen, B., Gordon, M., Kirsch, B., Gilstrap, C., Bagaria, S. & Jambusaria-Pahlajani, A., Jan 1 2015, In : Cancer immunology research. 3, 1, p. 18-22 5 p.

Research output: Contribution to journalArticle

Dermatitis
Melanoma
Exanthema
Immune System
Therapeutics
24 Citations (Scopus)

Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma

Ho, T. H., Kapur, P., Joseph, R. W., Serie, D. J., Eckel-Passow, J. E., Parasramka, M., Cheville, J. C., Wu, K. J., Frenkel, E., Rakheja, D., Stefanius, K., Brugarolas, J. & Parker, A., Jan 1 2015, In : Urologic Oncology. 33, 1

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Staining and Labeling
Neoplasms
BRCA1 Protein
Immunohistochemistry